K Cejvan, DH Coy, JJ Holst, E Cerasi, S … - Diabetes, 2002 - Am Diabetes Assoc Arginine-stimulated insulin and somatostatin release is enhanced by the
sulfonylurea gliclazide. In contrast, gliclazide inhibits the glucagon response.
The aim of the present study was to investigate whether this inhibition of ... Cited by 9 - Related articles - BL Direct - All 5 versions
K Takahashi, K TAMATANI, M Hara, H Sasaki - Diabetes research and clinical practice, 1994 - cat.inist.fr Gliclazide directly suppresses arginine-induced glucagon secretion. K TAKAHASHI,
K TAMATANI, M HARA, H SASAKI Diabetes research and ... Cited by 4 - Related articles - All 3 versions
Y Sako, T Wasada, F Umeda, H Ibayashi - Metabolism: clinical and experimental, 1986 - ncbi.nlm.nih.gov The effect of glibenclamide, a sulfonylurea agent, on islet hormone secretion,
particularly on glucagon was studied using isolated perifused pancreatic islets
of normal and cysteamine-treated rats. In normal rat islets, glibenclamide ... Cited by 11 - Related articles - All 2 versions
- ►uu.nl [PDF] - Free from Publisher EWMT ter Braak, AMMF Appelman, I van der … - Diabetes care, 2002 - Am Diabetes Assoc RESULTS—The increase in plasma glucagon with time from PG = 3.8 onward was
smaller for glyburide than for placebo (P = 0.014). Plasma glucagon area under
the curve (AUC) 60–180 was lower after glyburide than after placebo ... Cited by 13 - Related articles - BL Direct - All 6 versions
CG Östenson, A Nylen, V Grill, M Gutniak, S … - Diabetologia, 1986 - Springer Summary. The effects of sulfonylurea on glucagon secretion were characterized in
the perfused rat pancreas using gliben- clamide (1 ~tg/ml) or tolazamide (10
~tg/ml) in the presence of 3.3 mmol/1 glucose. Glucagon release, which was ... Cited by 16 - Related articles - All 3 versions
U Lindblad, A Melander - Diabetes Obesity and Metabolism, 2000 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 8 - Related articles - BL Direct - All 3 versions
E CERASI - 87.234.226.93 1. Hultin, T., Leon, HA & Cerasi, E.: Solubilization of labeled protein in cell
free amino acid incorporating systems from rat liver. Exp. Cell. Res. 25:
660-70, 1961. ... 2. Cerasi, E. & Luft, R.: Plasma insulin response to ... Related articles - View as HTML
- ►endojournals.org L Landstedt-Hallin, U Adamson, PE Lins - Journal of Clinical Endocrinology & Metabolism, 1999 - Endocrine Soc Intensifying pharmacological therapy in patients with type 2 diabetes increases
the risk of hypoglycemia and often requires the simultaneous use of more than
one agent. Combining insulin and sulfonylurea is an effective and ... Cited by 30 - Related articles - BL Direct - All 5 versions
